SV40 expression vector containing HBxAg as an expression marker
US4942125A · kind A · utility
8Cited by
1References
11Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 26, 1987 |
| Grant date | Jul 17, 1990 |
| Priority date | — |
| Expiry date | May 26, 2007 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/826
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Cloning and expression vectors for hepatitis B HBxAg, cell cultures containing those vectors, polypeptides related to HBxAg and diagnostic systems and methods for assaying for the presence of HBxAg and anti-HBxAg antibodies in a body sample are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.